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Recent reports describe an increase in the incidence of fatal adenovirus infections. Several severe cases
have been linked to adenovirus serotype 21. The exact etiology for this unexpectedly high mortality
remains unknown. We report the case of a patient with severe adenovirus serotype 21 pneumonia
resulting in hemophagocytic lymphohistiocytosis (HLH) with acute respiratory distress syndrome and
rapidly progressive multiorgan dysfunction syndrome (MODS). HLH describes a cytokine storm due to
uncontrolled accumulation of activated T-lymphocytes and activated histiocytes. This results in organ
inﬁltration with these cells, and subsequent hemophagocytosis of erythrocytes, leukocytes and platelets.
In its most severe form, HLH leads to a sepsis-like picture and MODS. The association between adeno-
virus 21 and HLH may at least in part explain the recently observed increase in incidence of fatal
adenoviral infections. We suggest that HLH should be considered in cases of severe adenoviral infection.
If HLH is present, aggressive treatment is warranted.
Published by Elsevier Ltd.Educational aims
The educational aims of this manuscript are to
 describe the etiology, manifestations, diagnosis, and treatment
of hemophagocytic lymphohistiocytosis (HLH)
 emphasize similarities between HLH and sepsis
 highlight the recent emergence of several cases of unusually
aggressive and fatal adenovirus infectionsof Medicine, 1481 West 10th
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type 21
 emphasize that the exact etiology for the unexpectedly high
mortality associated with adenovirus type 21 is unknown
 suggest that the reported association between adenovirus 21
and HLH in the present case may at least in part explain why
some patients infected with this adenovirus serotype experi-
ence severe and sometimes even fatal disease.1. Introduction
Several cases of unusually aggressive and fatal adenovirus
infections have recently been reported, some of which were
linked to adenovirus type 21.1–3 This adenovirus serotype has
recently been demonstrated to be more prevalent and more
virulent than previously described.3 The exact etiology for the
unexpectedly high mortality associated with this serotype
remains unknown. We report a 22-year-old male with severe
adenovirus serotype 21 pneumonia who developed hemopha-
gocytic lymphohistiocytosis (HLH) with acute respiratory
distress syndrome (ARDS) and severe multiorgan dysfunction
syndrome (MODS). The association between adenovirus 21 and
HLH may at least in part explain why some patients infected
Fig. 2. Right hilar lymph node, obtained at autopsy (H&E stain, 400 magniﬁcation).
The arrow indicates erythrocytophagocytosis by a macrophage.
T. Lahm et al. / Respiratory Medicine CME 3 (2010) 223–225224with adenovirus experience unusually severe and sometimes
fatal disease.
2. Case report
A 22-year-old Caucasian male with a remote history of juvenile
rheumatoid arthritis (JRA) was admitted with a 3-day history of
dyspnea, productive cough and fever unresponsive to outpatient
treatment with a macrolide. The patient had not been on immu-
nosuppressive medications for more than 2 years. The chest CT
revealed diffuse dense bilateral inﬁltrates (Fig. 1). Despite treat-
ment with vancomycin, piperacillin–tazobactam and levoﬂoxacin,
the patient remained febrile and developed rapidly progressive
ARDS requiring mechanical ventilation. Bronchoalveolar lavage
(BAL) initially did not reveal any pathogens. The patient developed
shock, acute renal failure andmetabolic acidosis, requiringmultiple
pressors and renal replacement therapy. Stress-dose hydrocorti-
sone was added without improvement. Four days after bronchos-
copy, the BAL viral culture grew adenovirus. The patient continued
to exhibit severe hypoxia and hypercarbia, and died of respiratory
failure on hospital day 12. During the patient’s clinical deteriora-
tion, his serum ferritin increased from 757 to 9490 ng/ml, and his
platelets decreased from 180,000 to 36,000/mm3. Disseminated
intravascular coagulation, active RA and systemic lupus eryth-
ematosus were excluded. The patient also developed hyper-
triglyceridemia (499 mg/dl) and anemia (8.6 mg/dl). A bone
marrow biopsy did not show any evidence of hemophagocytosis.
However, the postmortem examination revealed macrophages
with hemophagocytosis and lymphophagocytosis in a hilar lymph
node (Fig. 2). Decreased natural killer (NK) cell activity was
detected in the patient’s blood, although this result was not avail-
able until after the patient’s demise. Based on these results,
a postmortem diagnosis of adenovirus-induced HLH was made.
Serotyping of the isolated adenovirus at the Centers for Disease
Control revealed adenovirus serotype 21.
3. Discussion
Adenovirus usually causes self-limited upper respiratory tract
infections. While cases of severe adenovirus pneumonia in immu-
nocompetent adults have been described, the overall incidence is
extremely rare. Recently, several cases of fatal adenovirus pneu-
monia in immunocompetent as well as immunocompromised
patients were reported.1-3 Some of these were linked to adenovirus
serotype 21.3 Gray et al. demonstrated adenovirus 21 in 1% of
specimens in 2004, but 2.4% in 2006. Adenovirus 21 caused higherFig. 1. (A) Admission chest X-ray demonstrating right sided airspace opacities and small bila
inﬁltrates with air bronchograms and a right pleural effusion. In addition, right lower lobemorbidity andmortality than other serotypes, increasing the risk of
severe disease almost eightfold.3 The reason for the extremely high
virulence and mortality observed with adenovirus 21 remains
unknown.
HLH (also known as hemophagocytic syndrome) describes
a cytokine storm due to uncontrolled accumulation of activated T-
lymphocytes and histiocytes with subsequent organ inﬁltration
and hemophagocytosis of erythrocytes, leukocytes and platelets.4
In its most severe form, HLH leads to a sepsis-like picture and
MODS. The etiology of the syndrome includes defects in the per-
forin/granzyme pathway of NK- and/or cytotoxic T-cells, causing
failure of termination of the immune reponse and decreased
lymphocyte apoptosis. The syndrome usually occurs in infants,
children or young adults. It is categorized into genetic (or primary)
and acquired (or secondary) types. Primary HLH includes genetic
cases associated with familial HLH as well as cases associated with
several congenital immunodeﬁciencies like Griscelli syndrome,
Hermannsky–Pudlak syndrome or Chediak-Higashi syndrome.
Secondary HLH is usually due to viral infections (e.g. herpes
simplex virus, Ebstein–Barr virus, cytomegalovirus, varizella zoster
virus, human immunodeﬁciency virus, adenovirus), as well as
bacterial and parasitic infections, malignancies (mainly leukemia
and lymphoma), autoimmune disease (e.g. adult or juvenile rheu-
matoid arthritis, systemic lupus erythematosus), and medications.
When HLH is associated with rheumatic diseases, it is referred to as
macrophage activation syndrome (MAS).teral pleural effusions. (B) Chest CT on admission revealing right middle and upper lobe
and scattered left-sided opacities as well as a small left effusion are seen.
Table 1
Diagnostic criteria for Hemophagocytic Lymphohistiocytosis (HLH) [adapted from
Ref. 5].
1. Familial disease/known genetic defect (autosomal recessive)
or
2. Clinical and laboratory criteria (5/8 criteria)
 Fever*
 Splenomegaly
 Cytopenia 2 cell lines
Hemoglobin< 9 mg/dl*
Platelets< 100 109/l*
Neutrophils< 1 109/l
 Hypertriglyceridemia and/or hypoﬁbrinogenemia
Fasting triglycerides 265 mg/dl*
Fibrinogen< 150 mg/dl
 Ferritin> 500 ng/ml*
 sCD25 2400 U/ml
 Decreased or absent NK-cell activity**
 Hemophagocytosis in bone marrow, cerebrospinal ﬂuid or lymph nodes**
HLH is diagnosed in the presence of familial disease or a known genetic defect, or by
a combination of clinical and laboratory criteria (ﬁve out of eight criteria must be
present). *Indicates criteria that were met in the reported patient before his demise,
**Indicates criteria that were met postmortem. sCD25, soluble interleukin-2
receptor; NK-cell, natural killer cell.
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diagnosed by a combination of clinical and laboratory criteria5
(Table 1). The syndrome is often misdiagnosed as sepsis, thereby
precluding the potentially curative treatment with dexamethasone,
cyclosporine A and sometimes even etoposide and bone marrow
transplantation.6
It is conceivable that the recently observed increase in virulence
of adenovirus type 21 infections may in part be due to an associa-
tion with HLH. Adenovirus infection may unmask or exacerbate
previously undiagnosed HLH, which was likely the case in our
patient. The high mortality seen with other adenovirus serotypes
(e.g. type 14) may also be due to an association with HLH. Our
ﬁndings have two potential clinical implications: ﬁrst, this case
provides a potential partial explanation for the recent increase in
morbidity and mortality observed with adenoviral infections.
Second, our report suggests that HLH needs to be considered in
cases of severe adenoviral as well as other viral infections. If
present, HLH should be aggressively treated, as 1-year-survival for
untreated HLH is only 5%.7
4. Conclusion
HLH refers to a cytokine storm that is secondary to uncontrolled
accumulation of activated T-lymphocytes and histiocytes resulting
in organ inﬁltration with these cells, and hemophagocytosis of
erythrocytes, leukocytes and/or platelets. The syndrome results in
multiorgan dysfunction and a sepsis-like picture. The reported
association between adenovirus 21 and HLH seen in our patient
may at least in part explain why some patients infected with thisadenovirus serotype experience severe and sometimes even fatal
disease.
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